MedPath

Effects of various dialysates on electrolytes, cardiovascular system, hospitalization rate, life prognosis

Not Applicable
Conditions
Hemodialysis
Registration Number
JPRN-UMIN000034937
Lead Sponsor
Kawashima Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with peritoneal dialysis combined

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality rate Hospitalization rate, re-hospitalization rate Corrected Ca, P, intact-PTH, Mg Abdominal CT:calcification score
Secondary Outcome Measures
NameTimeMethod
Coronary artery CT: calcification score Vascular endothelial function (FMD) Intima-media complex thickness (IMT): upper arm IMT, carotid IMT ABI PWV Echocardiography: left atrium diameter (LAD), left ventricular end diastolic diameter (LADd), left ventricular ejection fraction (EF), extended early wave (e '), expanded early wave / extended early wave (E / e' ), Left ventricular mass coefficient (LVMI), ventricular septal thickness (IVS), left ventricular wall thickness (LVWT) Electrocardiogram: QTc Prescription drugs and injections (at the beginning and at the end / at the time of death): phosphorus adsorbents, vitamin D preparations, calcium receptor agonists, Mg-containing preparations Frequency of dialysis hypotension requiring replacement fluid Nutritional status: PCR, GNRI,% CGR, BMI, Alb, TP, ChE Periodic blood collection results: Hb, Ht, BUN, Cre, Na, Cl, Fe, ferritin, blood glucose (GA, HbA1c), B2-MG
© Copyright 2025. All Rights Reserved by MedPath